S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
pixel
Log in
NASDAQ:CRDF

Cardiff Oncology News Headlines

$9.72
+0.54 (+5.88 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.12
Now: $9.72
$9.81
50-Day Range
$9.18
MA: $12.03
$19.57
52-Week Range
$0.70
Now: $9.72
$25.50
Volume1.52 million shs
Average Volume2.28 million shs
Market Capitalization$360.15 million
P/E RatioN/A
Dividend YieldN/A
Beta1.8

Headlines

Cardiff Oncology (NASDAQ CRDF) News Headlines Today

Source:
SourceHeadline
Cardiff Oncology (NASDAQ:CRDF) Stock Price Up 5.9%Cardiff Oncology (NASDAQ:CRDF) Stock Price Up 5.9%
americanbankingnews.com - March 5 at 7:52 PM
Gary W. Pace Acquires 1,500 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) StockGary W. Pace Acquires 1,500 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) Stock
americanbankingnews.com - March 4 at 9:56 PM
Cardiff Oncology (NASDAQ:CRDF) Trading Down 8.9%Cardiff Oncology (NASDAQ:CRDF) Trading Down 8.9%
americanbankingnews.com - March 3 at 8:46 PM
Cardiff Oncology to Present at H.C. Wainwright Global Life Sciences ConferenceCardiff Oncology to Present at H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 3 at 8:45 AM
Could The Cardiff Oncology, Inc. (NASDAQ:CRDF) Ownership Structure Tell Us Something Useful?Could The Cardiff Oncology, Inc. (NASDAQ:CRDF) Ownership Structure Tell Us Something Useful?
finance.yahoo.com - February 27 at 9:52 AM
Cardiff Oncology (NASDAQ:CRDF) Stock Price Up 6.1%Cardiff Oncology (NASDAQ:CRDF) Stock Price Up 6.1%
americanbankingnews.com - February 26 at 7:19 PM
Cardiff Oncology (NASDAQ:CRDF) Announces  Earnings Results, Misses Expectations By $0.05 EPSCardiff Oncology (NASDAQ:CRDF) Announces Earnings Results, Misses Expectations By $0.05 EPS
americanbankingnews.com - February 26 at 1:46 PM
Cardiff Oncology Announces Fourth Quarter and Full Year 2020 Results and Recent HighlightsCardiff Oncology Announces Fourth Quarter and Full Year 2020 Results and Recent Highlights
finance.yahoo.com - February 25 at 7:40 PM
Cardiff Oncology (NASDAQ:CRDF) Stock Price Down 5.2%Cardiff Oncology (NASDAQ:CRDF) Stock Price Down 5.2%
americanbankingnews.com - February 25 at 7:16 PM
Cardiff Oncology to Participate in Gastrointestinal (GI) Oncology and Pancreatic Cancer Panel Discussion at the Cowen 41st Annual Health Care ConferenceCardiff Oncology to Participate in Gastrointestinal (GI) Oncology and Pancreatic Cancer Panel Discussion at the Cowen 41st Annual Health Care Conference
finance.yahoo.com - February 24 at 12:48 PM
Head to Head Analysis: Cardiff Oncology (NASDAQ:CRDF) & Mosaic ImmunoEngineering (OTCMKTS:CPMV)Head to Head Analysis: Cardiff Oncology (NASDAQ:CRDF) & Mosaic ImmunoEngineering (OTCMKTS:CPMV)
americanbankingnews.com - February 21 at 2:18 AM
Cardiff Oncology (NASDAQ:CRDF) Stock Price Down 8.1%Cardiff Oncology (NASDAQ:CRDF) Stock Price Down 8.1%
americanbankingnews.com - February 18 at 8:34 PM
Cardiff Oncology (CRDF) May Report Negative Earnings: Know the Trend Ahead of Q4 ReleaseCardiff Oncology (CRDF) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
msn.com - February 18 at 1:36 PM
Cardiff Oncology to Present at the LifeSci Partners Precision Oncology DayCardiff Oncology to Present at the LifeSci Partners Precision Oncology Day
finance.yahoo.com - February 16 at 2:52 PM
Cardiff Oncology (NASDAQ:CRDF) Stock Price Down 8.5%Cardiff Oncology (NASDAQ:CRDF) Stock Price Down 8.5%
americanbankingnews.com - February 12 at 8:18 PM
Cardiff Oncology (NASDAQ:CRDF) Trading 9.5% Higher Cardiff Oncology (NASDAQ:CRDF) Trading 9.5% Higher
americanbankingnews.com - February 11 at 7:52 PM
Cardiff Oncology Presents Phase 2 mCRPC Trial Data Showing a Two-Fold Increase in Efficacy with an Optimized Onvansertib Dosing ScheduleCardiff Oncology Presents Phase 2 mCRPC Trial Data Showing a Two-Fold Increase in Efficacy with an Optimized Onvansertib Dosing Schedule
finance.yahoo.com - February 11 at 12:37 PM
Why Cardiff Oncology Ran Up 1,350% in 2020Why Cardiff Oncology Ran Up 1,350% in 2020
msn.com - January 31 at 9:21 AM
Why Cardiff Oncology Stock Is Crashing TodayWhy Cardiff Oncology Stock Is Crashing Today
msn.com - January 15 at 12:47 PM
Cardiff Oncology Presents Data that Continues to Demonstrate the Clinical Benefit of Onvansertib in KRAS-Mutated mCRC and Initial Findings from its Expanded Access ProgramCardiff Oncology Presents Data that Continues to Demonstrate the Clinical Benefit of Onvansertib in KRAS-Mutated mCRC and Initial Findings from its Expanded Access Program
finance.yahoo.com - January 15 at 12:47 PM
Okyo Pharma Li. Regulatory NewsOkyo Pharma Li. Regulatory News
lse.co.uk - January 8 at 3:36 AM
Labcorp Awarded CDC Contract to Study Variants of COVID-19 Virus and Improve Public Health ResponseLabcorp Awarded CDC Contract to Study Variants of COVID-19 Virus and Improve Public Health Response
finance.yahoo.com - January 7 at 5:34 PM
Hudson Technologies Applauds Adoption of Omnibus/Covid-19 Relief Which Includes the Phasedown of HFC ProductionHudson Technologies Applauds Adoption of Omnibus/Covid-19 Relief Which Includes the Phasedown of HFC Production
finance.yahoo.com - December 29 at 9:09 AM
Cardiff Oncology Announces the Appointment of Dr. Rodney Markin as Chairman of the BoardCardiff Oncology Announces the Appointment of Dr. Rodney Markin as Chairman of the Board
finance.yahoo.com - December 21 at 5:33 PM
Walgreens and Labcorp Make Pixel by Labcorp™ At-Home COVID-19 Collection Kit Available Through Walgreens Find Care®Walgreens and Labcorp Make Pixel by Labcorp™ At-Home COVID-19 Collection Kit Available Through Walgreens Find Care®
finance.yahoo.com - December 21 at 7:23 AM
Hedge Funds Have Never Been This Bullish On Cardiff Oncology (CRDF)Hedge Funds Have Never Been This Bullish On Cardiff Oncology (CRDF)
finance.yahoo.com - December 16 at 3:22 PM
LabCorp receives FDA authorization for at-home COVID-19 kitsLabCorp receives FDA authorization for at-home COVID-19 kits
finance.yahoo.com - December 11 at 5:53 PM
LabCorp Receives FDA Authorization to Make At-Home COVID-19 Collection Kits Available Through RetailLabCorp Receives FDA Authorization to Make At-Home COVID-19 Collection Kits Available Through Retail
finance.yahoo.com - December 9 at 6:19 PM
Cardiff Oncology Presents Data at ASH Demonstrating the Safety and Anti-Leukemic Activity of Onvansertib in Patients with Relapsed/Refractory AMLCardiff Oncology Presents Data at ASH Demonstrating the Safety and Anti-Leukemic Activity of Onvansertib in Patients with Relapsed/Refractory AML
finance.yahoo.com - December 6 at 8:41 AM
Cardiff Oncology: A Breakout Darkhorse In The Booming K-Ras MarketCardiff Oncology: A Breakout Darkhorse In The Booming K-Ras Market
seekingalpha.com - November 24 at 10:07 AM
Cardiff Oncology to Participate in Fireside Chat at the Piper Sandler 32nd Annual Healthcare ConferenceCardiff Oncology to Participate in Fireside Chat at the Piper Sandler 32nd Annual Healthcare Conference
finance.yahoo.com - November 23 at 9:49 AM
Cardiff Oncology EPS in-line, beats on revenueCardiff Oncology EPS in-line, beats on revenue
seekingalpha.com - November 5 at 8:08 PM
Cardiff Oncology Announces Third Quarter 2020 Results and HighlightsCardiff Oncology Announces Third Quarter 2020 Results and Highlights
finance.yahoo.com - November 5 at 8:08 PM
Cardiff Oncology: A Solid Oncology Company With 50% Upside PotentialCardiff Oncology: A Solid Oncology Company With 50% Upside Potential
seekingalpha.com - November 3 at 2:45 PM
Have Insiders Been Buying Cardiff Oncology, Inc. (NASDAQ:CRDF) Shares?Have Insiders Been Buying Cardiff Oncology, Inc. (NASDAQ:CRDF) Shares?
finance.yahoo.com - October 25 at 12:30 PM
Why Cardiff Oncologys Stock Is Trading Higher TodayWhy Cardiff Oncology's Stock Is Trading Higher Today
benzinga.com - October 22 at 2:12 PM
Hudson Technologies to Host Conference Call to Discuss  Third Quarter 2020 ResultsHudson Technologies to Host Conference Call to Discuss Third Quarter 2020 Results
finance.yahoo.com - October 22 at 9:11 AM
Cardiff Oncologys onvansertib may overcome Zytiga resistance in prostate cancerCardiff Oncology's onvansertib may overcome Zytiga resistance in prostate cancer
seekingalpha.com - October 20 at 1:59 PM
Cardiff Oncology Inc.Cardiff Oncology Inc.
barrons.com - October 17 at 10:55 PM
Cardiff Oncologys Onvansertib Could Possibly End Up Being A Solid Cancer DrugCardiff Oncology's Onvansertib Could Possibly End Up Being A Solid Cancer Drug
seekingalpha.com - October 12 at 3:57 PM
Why Cardiff Oncology Stock Skyrocketed TodayWhy Cardiff Oncology Stock Skyrocketed Today
fool.com - October 8 at 5:21 PM
Cardiff Oncology Rakes In Over 200% Gain In 3 MonthsCardiff Oncology Rakes In Over 200% Gain In 3 Months
nasdaq.com - October 2 at 7:58 AM
Thinking about trading options or stock in Alibaba, Cardiff Oncology, Penn National Gaming, Facebook, or Target?Thinking about trading options or stock in Alibaba, Cardiff Oncology, Penn National Gaming, Facebook, or Target?
marketwatch.com - September 30 at 12:27 PM
Cardiff Oncology prices equity offering at $13.50Cardiff Oncology prices equity offering at $13.50
seekingalpha.com - September 30 at 7:17 AM
Cardiff Oncology readies equity offeringCardiff Oncology readies equity offering
seekingalpha.com - September 29 at 5:47 PM
Cardiff Oncology +1% on KOL event on September 23Cardiff Oncology +1% on KOL event on September 23
seekingalpha.com - September 17 at 11:15 PM
Insider Buys Cardiff Oncologys SharesInsider Buys Cardiff Oncology's Shares
finance.yahoo.com - September 17 at 11:15 PM
Cardiff Oncologys onvansertib shows sustained clinical benefit in colorectal cancerCardiff Oncology's onvansertib shows sustained clinical benefit in colorectal cancer
seekingalpha.com - September 17 at 11:15 PM
Cardiff Oncology Presents Data at ESMO Confirming Efficacy of Onvansertib and Durability of Response in KRAS-Mutated Metastatic Colorectal Cancer (mCRC)Cardiff Oncology Presents Data at ESMO Confirming Efficacy of Onvansertib and Durability of Response in KRAS-Mutated Metastatic Colorectal Cancer (mCRC)
finance.yahoo.com - September 17 at 8:13 AM
Cardiff Oncology to Present Data Further Demonstrating the Safety and Efficacy of Onvansertib in KRAS-Mutated Metastatic Colorectal Cancer PatientsCardiff Oncology to Present Data Further Demonstrating the Safety and Efficacy of Onvansertib in KRAS-Mutated Metastatic Colorectal Cancer Patients
finance.yahoo.com - September 14 at 9:25 AM
This page was last updated on 3/7/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.